CA2089143A1 - Compositions de facteur de croissance, leur preparation et leur utilisation - Google Patents

Compositions de facteur de croissance, leur preparation et leur utilisation

Info

Publication number
CA2089143A1
CA2089143A1 CA002089143A CA2089143A CA2089143A1 CA 2089143 A1 CA2089143 A1 CA 2089143A1 CA 002089143 A CA002089143 A CA 002089143A CA 2089143 A CA2089143 A CA 2089143A CA 2089143 A1 CA2089143 A1 CA 2089143A1
Authority
CA
Canada
Prior art keywords
pure
growth factor
species
hegf1
nicked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002089143A
Other languages
English (en)
Other versions
CA2089143C (fr
Inventor
Indu Parikh
Ronald Nardi
Tanchum Amarant
Antonio Guglietta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1991/005396 external-priority patent/WO1992002246A1/fr
Publication of CA2089143A1 publication Critical patent/CA2089143A1/fr
Application granted granted Critical
Publication of CA2089143C publication Critical patent/CA2089143C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002089143A 1990-08-02 1991-07-30 Compositions de facteur de croissance, leur preparation et leur utilisation Expired - Fee Related CA2089143C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56152590A 1990-08-02 1990-08-02
US59139990A 1990-10-01 1990-10-01
US591,399 1990-10-01
US561,525 1990-10-01
PCT/US1991/005396 WO1992002246A1 (fr) 1990-08-02 1991-07-30 Compositions de facteur de croissance, preparation et emploi

Publications (2)

Publication Number Publication Date
CA2089143A1 true CA2089143A1 (fr) 1992-02-03
CA2089143C CA2089143C (fr) 2002-01-15

Family

ID=27072671

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002089143A Expired - Fee Related CA2089143C (fr) 1990-08-02 1991-07-30 Compositions de facteur de croissance, leur preparation et leur utilisation

Country Status (1)

Country Link
CA (1) CA2089143C (fr)

Also Published As

Publication number Publication date
CA2089143C (fr) 2002-01-15

Similar Documents

Publication Publication Date Title
CA2239174A1 (fr) Nouveaux composes a effet analgesique
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
IE830479L (en) Carboxyalkyl dipeptides
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
BG103947A (en) Derivatives of 9-oxymerythromycin
AU3850600A (en) Dalda analogs and their use
EP0664128A4 (fr) Composition pharmaceutique utilisee pour inhiber la production des facteurs de necrose tumorale.
EP1310256A3 (fr) Utilisation de la prostaglandine A ou de ses dérivés pour le traitement du psoriasis
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
CA2029657A1 (fr) Compositions pharmaceutiques permettant de reduire la tension intra-oculaire et mode d'utilisation
EP0992509A3 (fr) Nouveaux dérivés macrolides
CA2155323A1 (fr) Nouvelle utilisation de composes bis-heterocycliques comme agents anti-inflammatoires; compositions pharmaceutiques de ces agents
CA2314154A1 (fr) Derives d'azepine et leur utilisation comme produits pharmaceutiques
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
CA2300289A1 (fr) Composition pharmaceutique active dans la reduction de production de proteine mcp-1
AU2420001A (en) Methods and compositions for the treatment of pain
HK1018783A1 (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5 α-REDUCTASES INHIBITORS
IE801163L (en) Paromomycin derivatives
EP0541726A4 (en) Growth factor compositions, preparation and use
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
CA2089143A1 (fr) Compositions de facteur de croissance, leur preparation et leur utilisation
AU636178B2 (en) 7 (alanylaminothiazol-iminoacetamide) substituted cephalosporin derivatives
AU8643698A (en) Controlled release pharmaceutical compositions containing tiagabine
AP9801235A0 (en) Erythromycin derivatives.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed